Literature DB >> 32938729

T Cells from NOD-PerIg Mice Target Both Pancreatic and Neuronal Tissue.

Jeremy J Racine1, Harold D Chapman1, Rosalinda Doty1, Brynn M Cairns1, Timothy J Hines1, Abigail L D Tadenev1, Laura C Anderson1, Torrian Green1, Meaghan E Dyer1, Janine M Wotton1, Zoë Bichler1, Jacqueline K White1, Rachel Ettinger2,3, Robert W Burgess1, David V Serreze4.   

Abstract

It has become increasingly appreciated that autoimmune responses against neuronal components play an important role in type 1 diabetes (T1D) pathogenesis. In fact, a large proportion of islet-infiltrating B lymphocytes in the NOD mouse model of T1D produce Abs directed against the neuronal type III intermediate filament protein peripherin. NOD-PerIg mice are a previously developed BCR-transgenic model in which virtually all B lymphocytes express the H and L chain Ig molecules from the intra-islet-derived anti-peripherin-reactive hybridoma H280. NOD-PerIg mice have accelerated T1D development, and PerIg B lymphocytes actively proliferate within islets and expand cognitively interactive pathogenic T cells from a pool of naive precursors. We now report adoptively transferred T cells or whole splenocytes from NOD-PerIg mice expectedly induce T1D in NOD.scid recipients but, depending on the kinetics of disease development, can also elicit a peripheral neuritis (with secondary myositis). This neuritis was predominantly composed of CD4+ and CD8+ T cells. Ab depletion studies showed neuritis still developed in the absence of NOD-PerIg CD8+ T cells but required CD4+ T cells. Surprisingly, sciatic nerve-infiltrating CD4+ cells had an expansion of IFN-γ- and TNF-α- double-negative cells compared with those within both islets and spleen. Nerve and islet-infiltrating CD4+ T cells also differed by expression patterns of CD95, PD-1, and Tim-3. Further studies found transitory early B lymphocyte depletion delayed T1D onset in a portion of NOD-PerIg mice, allowing them to survive long enough to develop neuritis outside of the transfer setting. Together, this study presents a new model of peripherin-reactive B lymphocyte-dependent autoimmune neuritis.
Copyright © 2020 by The American Association of Immunologists, Inc.

Entities:  

Year:  2020        PMID: 32938729      PMCID: PMC7694871          DOI: 10.4049/jimmunol.2000114

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  40 in total

1.  Anti-peripherin B lymphocytes are positively selected during diabetogenesis.

Authors:  Jorge Carrillo; Maria Carmen Puertas; Raquel Planas; Xavier Pastor; Aurora Alba; Thomas Stratmann; Ricardo Pujol-Borrell; Rosa Maria Ampudia; Marta Vives-Pi; Joan Verdaguer
Journal:  Mol Immunol       Date:  2008-04-23       Impact factor: 4.407

2.  Type I diabetes and multiple sclerosis patients target islet plus central nervous system autoantigens; nonimmunized nonobese diabetic mice can develop autoimmune encephalitis.

Authors:  S Winer; I Astsaturov; R Cheung; L Gunaratnam; V Kubiak; M A Cortez; M Moscarello; P W O'Connor; C McKerlie; D J Becker; H M Dosch
Journal:  J Immunol       Date:  2001-02-15       Impact factor: 5.422

3.  Distinct effector mechanisms in the development of autoimmune neuropathy versus diabetes in nonobese diabetic mice.

Authors:  Hélène Bour-Jordan; Heather L Thompson; Jeffrey A Bluestone
Journal:  J Immunol       Date:  2005-11-01       Impact factor: 5.422

4.  Chromogranin A is an autoantigen in type 1 diabetes.

Authors:  Brian D Stadinski; Thomas Delong; Nichole Reisdorph; Richard Reisdorph; Roger L Powell; Michael Armstrong; Jon D Piganelli; Gene Barbour; Brenda Bradley; Frances Crawford; Philippa Marrack; Sushil K Mahata; John W Kappler; Kathryn Haskins
Journal:  Nat Immunol       Date:  2010-02-07       Impact factor: 25.606

5.  PD-1 deficiency reveals various tissue-specific autoimmunity by H-2b and dose-dependent requirement of H-2g7 for diabetes in NOD mice.

Authors:  Taku Yoshida; Fang Jiang; Tasuku Honjo; Taku Okazaki
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-25       Impact factor: 11.205

6.  Interleukin-6 induces expression of peripherin and cooperates with Trk receptor signaling to promote neuronal differentiation in PC12 cells.

Authors:  E Sterneck; D R Kaplan; P F Johnson
Journal:  J Neurochem       Date:  1996-10       Impact factor: 5.372

7.  Origin of the beta cells of the islets of Langerhans is further questioned by the expression of neuronal intermediate filament proteins, peripherin and NF-L, in the rat insulinoma RIN5F cell line.

Authors:  M Escurat; K Djabali; C Huc; F Landon; C Bécourt; C Boitard; F Gros; M M Portier
Journal:  Dev Neurosci       Date:  1991       Impact factor: 2.984

8.  Reduced number of unmyelinated sensory axons in peripherin null mice.

Authors:  R C Larivière; M D Nguyen; A Ribeiro-da-Silva; J-P Julien
Journal:  J Neurochem       Date:  2002-05       Impact factor: 5.372

9.  Loss of intra-islet CD20 expression may complicate efficacy of B-cell-directed type 1 diabetes therapies.

Authors:  David V Serreze; Harold D Chapman; Marijke Niens; Robert Dunn; Marilyn R Kehry; John P Driver; Michael Haller; Clive Wasserfall; Mark A Atkinson
Journal:  Diabetes       Date:  2011-09-16       Impact factor: 9.461

10.  Isolation of antigen-binding cells from unprimed mice: demonstration of antibody-forming cell precursor activity and correlation between precursor and secreted antibody avidities.

Authors:  M H Julius; L A Herzenberg
Journal:  J Exp Med       Date:  1974-10-01       Impact factor: 14.307

View more
  1 in total

Review 1.  The NOD Mouse Beyond Autoimmune Diabetes.

Authors:  Anne-Marie Aubin; Félix Lombard-Vadnais; Roxanne Collin; Holly A Aliesky; Sandra M McLachlan; Sylvie Lesage
Journal:  Front Immunol       Date:  2022-04-29       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.